Transforming growth factor β induces fibroblast fibrillin‐1 matrix formation
Open Access
- 8 November 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (11) , 3000-3009
- https://doi.org/10.1002/art.10621
Abstract
Objective: Fibrillin, an extracellular matrix protein implicated in dermal fibrosis, is increased in the reticular dermis of systemic sclerosis (SSc) skin. We undertook this study to investigate the hypothesis that transforming growth factor β (TGFβ) or other cytokines regulate fibrillin matrix formation by normal and SSc fibroblasts. We further investigated the mechanism of TGFβ‐induced fibrillin fibrillogenesis and its relationship to myofibroblasts.Methods: Fibrillin and fibronectin matrix deposition and α‐smooth muscle actin expression by fibroblast cultures from normal and SSc skin treated with TGFβ or other cytokines were analyzed by immunofluorescence. Supernatant and extracellular matrix from normal and SSc fibroblasts treated with or without TGFβ were evaluated by Western blot and Northern blot for fibrillin protein and messenger RNA (mRNA) expression, respectively.Results: Immunofluorescence demonstrated increased fibrillin matrix formation by normal and scleroderma fibroblasts after TGFβ treatment. Other cytokines, including tumor necrosis factor α, interleukin‐1β (IL‐1β), IL‐4, granulocyte–macrophage colony‐stimulating factor, and platelet‐derived growth factor, did not affect fibrillin fibrillogenesis. Fibrillin matrix formed in proximity to myofibroblasts and independently of up‐regulation of fibronectin matrix or cell number. Western blot analysis of extracellular matrix confirmed increased fibrillin after TGFβ stimulation of normal or scleroderma fibroblasts. However, TGFβ did not alter the expression of either soluble fibrillin protein or fibrillin mRNA.Conclusion: Our data show that TGFβ induces fibrillin protein incorporation into the extracellular matrix without affecting fibrillin gene expression or protein synthesis, suggesting that fibrillin matrix assembly is regulated extracellularly. TGFβ might increase fibrillin matrix by activating myofibroblasts. Such TGFβ‐mediated effects could account for the increased fibrillin matrix observed in SSc skin.Keywords
This publication has 43 references indexed in Scilit:
- A Recessive Form of the Ehlers–Danlos Syndrome Caused by Tenascin-X DeficiencyNew England Journal of Medicine, 2001
- Marfan Syndrome: New Clues to Genotype—Phenotype CorrelationsAnnals of Medicine, 1999
- Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndromeNature Genetics, 1997
- A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.Genome Research, 1996
- Immunohistological Demonstration of Transforming Growth Factor-β Isoforms in the Skin of Patients with Systemic SclerosisClinical Immunology and Immunopathology, 1993
- Skin distribution and differential expression of transforming growth factor β1 and β2Journal of Dermatological Science, 1992
- Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?Journal of Investigative Dermatology, 1990
- Transforming Growth Factor-Beta: Selective Increase in Glycosaminoglycan Synthesis by Cultures of Fibroblasts From Patients With Progressive Systemic SclerosisJournal of Investigative Dermatology, 1987
- Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.The Journal of cell biology, 1986